Emergency use permit .. “Pfizer” and “Beautique” submit their vaccine to “FDA”

0
9


After the United States recorded a record total of coronavirus cases

Today, Saturday, Pfizer and Biontech submitted their Corona virus vaccine to the US Food and Drug Administration (FDA) to obtain an emergency use permit.

If approved, the vaccine may be used before the New Year.

According to “CNN Arabia”: This comes at a time when the United States reported a record total of new Coronavirus cases in one day.

Yesterday, the US Food and Drug Administration announced that it will meet with Pfizer and Biontech on December 10 to discuss licensing the emergency use of their joint vaccine.

Pfizer has submitted a request to the concerned health authorities in the United States to approve the emergency use of the Covid-19 vaccine, which is the first such request in a major step towards providing protection from the emerging corona virus.

The application to the US Food and Drug Administration comes days after Pfizer and its German partner Biontech announced the results of the final trials, which showed that the vaccine is 95 percent effective in preventing Covid-19 without any safety concerns.

Shares of Pfizer rose 1.6 percent, and shares of Biontech rose 6 percent, after news of the possibility of a vaccine being available soon. This has raised hopes of ending a pandemic that has claimed the lives of more than a quarter of a million people in the United States and more than 1.3 million in various parts of the world.

The request also includes safety data for 100 children between the ages of 12 and 15, and the company said that 45 percent of the participants in the US trials are between the ages of 56 and 85.

US Health Secretary Alex Azar told CBS News: If the data is strong, “we may have literally weeks before getting a license for a 95 percent effective vaccine.”

The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.

They said they would start shipping the doses immediately, and Pfizer said it expects to have 50 million vaccine doses ready this year, enough to protect 25 million people.

The new corona virus

Emergency use permit .. “Pfizer” and “Beautique” submit their vaccine to “FDA”

Previously

Today, Saturday, Pfizer and Biontech submitted their Corona virus vaccine to the US Food and Drug Administration (FDA) to obtain an emergency use permit.

If approved, the vaccine may be used before the New Year.

According to “CNN Arabia”: This comes at a time when the United States reported a record total of new Coronavirus cases in one day.

Yesterday, the US Food and Drug Administration announced that it will meet with Pfizer and Biontech on December 10 to discuss licensing the emergency use of their joint vaccine.

Pfizer has submitted a request to the concerned health authorities in the United States to approve the emergency use of the Covid-19 vaccine, which is the first such request in a major step towards providing protection from the emerging corona virus.

The application to the US Food and Drug Administration comes days after Pfizer and its German partner Biontech announced the results of the final trials, which showed that the vaccine is 95 percent effective in preventing Covid-19 without any safety concerns.

Shares of Pfizer rose 1.6 percent, and shares of Biontech rose 6 percent, after news of the possibility of a vaccine being available soon. This has raised hopes of ending a pandemic that has claimed the lives of more than a quarter of a million people in the United States and more than 1.3 million in various parts of the world.

The request also includes safety data for 100 children between the ages of 12 and 15, and the company said that 45 percent of the participants in the US trials are between the ages of 56 and 85.

US Health Secretary Alex Azar told CBS News: If the data is strong, “we may have literally weeks before getting a license for a 95 percent effective vaccine.”

The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.

They said they would start shipping the doses immediately, and Pfizer said it expects to have 50 million vaccine doses ready this year, enough to protect 25 million people.

November 21, 2020 – Rabi` al-Thani 6, 1442

12:32 PM


After the United States recorded a record total of coronavirus cases

Today, Saturday, Pfizer and Biontech submitted their Corona virus vaccine to the US Food and Drug Administration (FDA) to obtain an emergency use permit.

If approved, the vaccine may be used before the New Year.

According to “CNN Arabia”: This comes at a time when the United States reported a record total of new Coronavirus cases in one day.

Yesterday, the US Food and Drug Administration announced that it will meet with Pfizer and Biontech on December 10 to discuss licensing the emergency use of their joint vaccine.

Pfizer has submitted a request to the concerned health authorities in the United States to approve the emergency use of the Covid-19 vaccine, which is the first such request in a major step towards providing protection from the emerging corona virus.

The application to the US Food and Drug Administration comes days after Pfizer and its German partner Biontech announced the results of the final trials, which showed that the vaccine is 95 percent effective in preventing Covid-19 without any safety concerns.

Shares of Pfizer rose 1.6 percent, and shares of Biontech rose 6 percent, after news of the possibility of a vaccine being available soon. This has raised hopes of ending a pandemic that has claimed the lives of more than a quarter of a million people in the United States and more than 1.3 million in various parts of the world.

The request also includes safety data for 100 children between the ages of 12 and 15, and the company said that 45 percent of the participants in the US trials are between the ages of 56 and 85.

US Health Secretary Alex Azar told CBS News: If the data is strong, “we may have literally weeks before getting a license for a 95 percent effective vaccine.”

The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.

They said they would start shipping the doses immediately, and Pfizer said it expects to have 50 million vaccine doses ready this year, enough to protect 25 million people.

LEAVE A REPLY

Please enter your comment!
Please enter your name here